<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02930382</url>
  </required_header>
  <id_info>
    <org_study_id>BARODEF</org_study_id>
    <nct_id>NCT02930382</nct_id>
  </id_info>
  <brief_title>Assessment of Spontaneous Baroreflex Sensitivity in Carriers of Implantable Cardioverter Defibrillators: Association With Disorders of the Ventricular Heart Rate. Case-control Study</brief_title>
  <acronym>BARODEF</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <brief_summary>
    <textblock>
      We must implement 8 implantable cardioverter defibrillators (ICDs) to save a life in 3 years
      after myocardial infarction (MI) in primary prevention.

      Only the ejection fraction of the left ventricle (LVEF) is used as a tool for risk
      stratification of sudden death after myocardial infarction.

      Several studies have shown that impairment of spontaneous baroreflex sensitivity (BRS) after
      MI was predictor of sudden death.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2015</start_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>spontaneous baroreflex sensitivity by the sequence method (mean slope) during an active tilt</measure>
    <time_frame>10 days</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>BAROREFLEX</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Baroreflec assessment</intervention_name>
    <arm_group_label>BAROREFLEX</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients implanted with an implantable cardioverter defibrillators for primary
             prevention of ischemic heart disease with ejection fraction of the left ventricle ≤
             35%

          -  Ejection fraction of the left ventricle ≤ 35%

          -  Age ≥ 18 years

          -  Patients with disorders of the ventricular heart rate recorded by the implantable
             cardioverter defibrillators and not older than 2 years

          -  Implantable cardioverter defibrillators patient carrier for at least 3 years.

          -  Lack of disorders of ventricular heart rate in the memories of the implantable
             cardioverter defibrillators in the last three years prior to study entry

        Exclusion Criteria:

          -  Patient electro-driven,

          -  Patients with cardiac disease other qu'ischémique,

          -  Manifest impossibility of a collection of stationary signal Finapres: Atrial
             fibrillation, many premature, unsuccessful execution of verticalization,

          -  Important metabolic disorders such as ketoacidosis or dyskaliémie (&lt;3.5 or&gt; 5 mmol /
             L)

          -  Age &lt;18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rodrigue GARCIA</last_name>
    <email>rodrigue.garcia@chu-poitiers.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU DE Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rodrigue GARCIA</last_name>
      <email>rodrigue.garcia@chu-poitiers.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2016</study_first_submitted>
  <study_first_submitted_qc>October 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 12, 2016</study_first_posted>
  <last_update_submitted>October 12, 2016</last_update_submitted>
  <last_update_submitted_qc>October 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

